|
Index of reports
> Cases resulting in life threatening events (5)
Below is the selection of adverse event reports related to Pletal (Cilostazol) that includes cases resulting in life threatening events.
Adverse event in female receiving Pletal (Cilostazol)
Reported by a physician from Japan on 2007-06-29
Patient: female
Adverse reactions / side effects: Electrocardiogram QT Prolonged, Torsade DE Pointes
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Gaster
Dosage: daily dose:20mg
Administration route: Oral
Indication: Gastric Ulcer
Norvasc
Dosage: daily dose:5mg
Administration route: Oral
Indication: Hypertension
Pletal
Dosage: daily dose:200mg
Administration route: Oral
Symmetrel
Dosage: daily dose:150mg
Administration route: Oral
Indication: Parkinsonism
Other drugs received by patient: Diovan; Lipitor; Cabaser; Madopar; Ferromia; Warfarin Sodium
Adverse event in 91 year old male receiving Pletal (Cilostazol)
Reported by a pharmacist from United States on 2007-03-15
Patient: 91 year old male, weighing 88.5 kg (194.6 pounds)
Adverse reactions / side effects: Thrombocytopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Pletal (Cilostazol)
Other drugs received by patient: Gabapentin; Avapro; Furosemide; Levaquin; Glipizide; Tylenol
Adverse event in 59 year old male receiving Pletal (Cilostazol)
Reported by a physician from Japan on 2007-02-28
Patient: 59 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Drug Eruption, Neutrophil Count Increased, Biopsy Bone Marrow, Blood Lactate Dehydrogenase Increased, Chills, Eczema, Pyrexia, Idiopathic Thrombocytopenic Purpura, Diarrhoea, Pigmentation Disorder, Platelet Count Decreased, Thrombocytopenia, Enterocolitis, Lymphocyte Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Common Cold Medicine
Administration route: Oral
Indication: Nasopharyngitis
Start date: 2006-08-18
End date: 2006-08-18
Pletal
Dosage: 200 mg/day
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2006-06-17
End date: 2006-08-21
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Indication: Facial Spasm
Start date: 2006-08-09
End date: 2006-08-21
Other drugs received by patient: SLO-BID; Spiropent; Rivotril; Rivotril
Adverse event in 59 year old male receiving Pletal (Cilostazol)
Reported by a physician from Japan on 2007-02-05
Patient: 59 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Drug Eruption, Neutrophil Count Increased, Biopsy Bone Marrow, Blood Lactate Dehydrogenase Increased, Chills, Eczema, Pyrexia, Idiopathic Thrombocytopenic Purpura, Diarrhoea, Pigmentation Disorder, Platelet Count Decreased, Thrombocytopenia, Enterocolitis, Lymphocyte Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Common Cold Medicine
Administration route: Oral
Indication: Nasopharyngitis
Start date: 2006-08-18
End date: 2006-08-18
Pletal
Dosage: 200 mg/day
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2006-06-17
End date: 2006-08-21
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Indication: Facial Spasm
Start date: 2006-08-09
End date: 2006-08-21
Other drugs received by patient: SLO-BID; Spiropent; Rivotril; Rivotril
Adverse event in receiving Pletal (Cilostazol)
Reported by a individual with unspecified qualification from United States on 2007-01-23
Patient:
Adverse reactions / side effects: Tachycardia
Adverse event resulted in: life threatening event
Suspect drug(s):
Pletal (Cilostazol)
|
